NCT05518734View on ClinicalTrials.gov

A Phase 1 Dose Escalation Study of VX-708 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

September 17, 2022

Primary Completion Date

March 7, 2023

Study Completion Date

March 7, 2023

Conditions
Pain
Interventions
DRUG

VX-708

Solution for intravenous (IV) administration.

DRUG

Itraconazole

Solution for oral administration.

DRUG

Midazolam

Solution for oral administration.

DRUG

Placebo

Placebo matched to VX-708 for IV administration.

Trial Locations (1)

85283

Celerion - Tempe, Tempe

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY